AstraZeneca, Daiichi niche drug shows promise beyond breast cancer

AstraZeneca and Daiichi Sankyo's Enhertu helped patients with three different types of cancer live longer in trials, pointing to potential broader use of the breast cancer treatment.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news